- Profile
- prev
- next
General
-
Headquarters
Walnut Creek, California 94598, United States
-
Founders & Team
Stelios Tzannis
-
Year Founded
2005
-
Number of employees
10
-
Company type
Private company
-
Funding stage
Series A
-
Total funding ($M)
37.0
-
Investors
Apollo Health Ventures, Sofinnova, VenBio, Evotec, Evotec SE, venBio Partners
Technical Details
-
Aging Target
Altered intercellular communication
-
Product modality
small molecule drugs
About
We are a San Francisco Bay Area-based research stage biopharmaceutical company aiming to discover, develop and commercialize innovative therapeutics for the treatment of rare and age-related diseases.
We are developing compounds to modulate molecular pathways that address the underlying causes of disease initiation and progression, such as oxidative, cellular and environmental stress.